These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36267414)

  • 21. Weighted gene co-expression network analysis revealed key biomarkers associated with the diagnosis of hypertrophic cardiomyopathy.
    Li X; Wang C; Zhang X; Liu J; Wang Y; Li C; Guo D
    Hereditas; 2020 Oct; 157(1):42. PubMed ID: 33099311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modification of m6A mediates tissue immune microenvironment in calcific aortic valve disease.
    Chen JY; Xiong T; Sun YR; Cong J; Gong JS; Peng L; Rong YW; Wang ZY; Chang Q
    Ann Transl Med; 2022 Sep; 10(17):931. PubMed ID: 36172101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of biomarkers correlated with hypertrophic cardiomyopathy with co-expression analysis.
    Chen R; Ge T; Jiang W; Huo J; Chang Q; Geng J; Shan Q
    J Cell Physiol; 2019 Dec; 234(12):21999-22008. PubMed ID: 31059139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma.
    Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X
    Front Genet; 2022; 13():872186. PubMed ID: 35937991
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular subtype identification and predictive power of N6-methyladenosine regulator in unexplained recurrent pregnancy loss.
    Huo J; Chen Q; Zhang Y; Li N; Fu Z; Ma N; Zheng N; Cui N; Li L
    Front Genet; 2022; 13():925652. PubMed ID: 36118846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. m6A regulator-mediated RNA methylation modification patterns and immune microenvironment infiltration characterization in severe asthma.
    Sun D; Yang H; Fan L; Shen F; Wang Z
    J Cell Mol Med; 2021 Nov; 25(21):10236-10247. PubMed ID: 34647423
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of Underlying Hub Genes Associated with Hypertrophic Cardiomyopathy by Integrated Bioinformatics Analysis.
    Ma Z; Wang X; Lv Q; Gong Y; Xia M; Zhuang L; Lu X; Yang Y; Zhang W; Fu G; Ye Y; Lai D
    Pharmgenomics Pers Med; 2021; 14():823-837. PubMed ID: 34285551
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNA N6-Methyladenosine Regulators Contribute to Tumor Immune Microenvironment and Have Clinical Prognostic Impact in Breast Cancer.
    Mu LX; Shao YC; Wei L; Chen FF; Zhang JW
    Front Genet; 2021; 12():650499. PubMed ID: 35095993
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification of RNA N6-methyladenosine regulation in epilepsy: Significance of the cell death mode, glycometabolism, and drug reactivity.
    Liu X; Sun Q; Cao Z; Liu W; Zhang H; Xue Z; Zhao J; Feng Y; Zhao F; Wang J; Wang X
    Front Genet; 2022; 13():1042543. PubMed ID: 36468034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of key genes for hypertrophic cardiomyopathy using integrated network analysis of differential lncRNA and gene expression.
    Cao J; Yuan L
    Front Cardiovasc Med; 2022; 9():946229. PubMed ID: 35990977
    [TBL] [Abstract][Full Text] [Related]  

  • 31. M6A plays a potential role in carotid atherosclerosis by modulating immune cell modification and regulating aging-related genes.
    Zhao W; Xu Y; Zhu J; Zhang C; Zhou W; Wang S
    Sci Rep; 2024 Jan; 14(1):60. PubMed ID: 38168909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. m6A regulator-mediated RNA methylation modification patterns and immune microenvironment infiltration characterization in patients with intracranial aneurysms.
    Maimaiti A; Turhon M; Cheng X; Su R; Kadeer K; Axier A; Ailaiti D; Aili Y; Abudusalamu R; Kuerban A; Wang Z; Aisha M
    Front Neurol; 2022; 13():889141. PubMed ID: 35989938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a novel m6A-related lncRNA pair signature for predicting the prognosis of gastric cancer patients.
    Wang JM; Li X; Yang P; Geng WB; Wang XY
    BMC Gastroenterol; 2022 Feb; 22(1):76. PubMed ID: 35189810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. DNER and GNL2 are differentially m6A methylated in periodontitis in comparison with periodontal health revealed by m6A microarray of human gingival tissue and transcriptomic analysis.
    Wang Z; Chen H; Peng L; He Y; Wei J; Zhang X
    J Periodontal Res; 2023 Jun; 58(3):529-543. PubMed ID: 36941720
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic signature, subtype classification, and immune infiltration of key m6A regulators in osteomyelitis patients.
    Shi X; Ni H; Wu Y; Guo M; Wang B; Zhang Y; Zhang B; Xu Y
    Front Genet; 2022; 13():1044264. PubMed ID: 36544487
    [No Abstract]   [Full Text] [Related]  

  • 36. Identification and analysis of key hypoxia- and immune-related genes in hypertrophic cardiomyopathy.
    Yu H; Gu L; Du L; Dong Z; Li Z; Yu M; Yin Y; Wang Y; Yu L; Ma H
    Biol Res; 2023 Aug; 56(1):45. PubMed ID: 37559135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploring the Communal Pathogenesis, Ferroptosis Mechanism, and Potential Therapeutic Targets of Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy
    Wang Z; Xia Q; Su W; Cao M; Sun Y; Zhang M; Chen W; Jiang T
    Front Cardiovasc Med; 2022; 9():824756. PubMed ID: 35282347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Necroptosis and immune infiltration in hypertrophic cardiomyopathy: novel insights from bioinformatics analyses.
    Hou C; Fei S; Jia F
    Front Cardiovasc Med; 2024; 11():1293786. PubMed ID: 38947229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
    BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contributions and Prognostic Values of N6-Methyladenosine RNA Methylation Regulators in Hepatocellular Carcinoma.
    Qi LW; Jia JH; Jiang CH; Hu JM
    Front Genet; 2020; 11():614566. PubMed ID: 33519919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.